Therapeutic significance of surgery in advanced neuroblastoma: A report from the study group of Japan (Q68196748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Therapeutic significance of surgery in advanced neuroblastoma: A report from the study group of Japan (English)

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

17 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

17 October 2022

author name string

Y. Tsuchida

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

J. Yokoyama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

M. Kaneko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

J. Uchino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

M. Iwafuchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

S. Makino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

S. Matsuyama

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

H. Takahashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

I. Okabe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

K. Hashizume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1625134

17 October 2022

language of work or name

English

0 references

publication date

1 May 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:002234689290461F?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

https://api.elsevier.com/content/article/PII:002234689290461F?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Journal of Pediatric Surgery

17 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

616-622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group

22 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

The role of surgery in localized neuroblastoma

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

NEUROBLASTOMA IN INFANCY AND CHILDHOOD

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Improvement in survival after excision of primary tumor in stage III neuroblastoma

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

An evaluation of the role of surgery in metastatic neuroblastoma

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Intensive chemotherapy for metastatic neuroblastoma: a Southwest Oncology Group study

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimen

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan.

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

A proposed staging for children with neuroblastoma.Children's cancer study group A

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

17 October 2022

Staging of neuroblastoma

15

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Nonparametric Estimation from Incomplete Observations

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Resection of advanced stage neuroblastoma with the cavitron ultrasonic surgical aspirator

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Informing a patient of malignant illness: commentary from a cross-cultural viewpoint

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

The role of multimodal therapy in patients with local and regional neuroblastoma

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0022-3468(92)90461-F

17 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1625134%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference